Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Ig-Innovations

Ig-Innovations Ltd is a brand new company with over 30 years experience in antibody production and immunoassay development. Confusing but true – the experience and expertise is in the people we employ not the name we give the company. Born-out of the acquisition of the diagnostics division of MicroPharm, Ig has captured the skills and expertise developed during the research and development of sheep derived polyclonal antibodies for human therapy (now FDA & MHRA licensed products), diagnostics and research.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Ig-Innovations
Gernos, Maesllyn, Llandysul, SA44 5LP
+44 (0)1239 858972
Contact Ig-Innovations
Website

 Latest Content from PMHub 

Mobile Flexibility – Perks of Virtual Medical Education

Videos and Podcasts | July 4, 2024 | Impetus Digital

Unlock the potential of virtual collaboration with mobile flexibility! Discover how the latest technologies enable you to engage in medical education and collaborate from any corner of the globe. Watch...

The Importance of LGBTQ Diversity in Healthcare

Press Releases | July 3, 2024 | Mednet

We take a look at the importance of ensuring diversity in the Pharma industry

Surrogate endpoints in HTA: Reflections on my HTAi panel discussion

Press Releases | July 2, 2024 | Petauri Evidence

Calum Jones (Associate Director – Health Economics, Mtech Access) shares his experience of speaking at the 2024 HTAi Annual Meeting. Calum participated in the panel discussion: ‘Surrogate Endpoints in Health...

US and European Market Access for Medical Devices – Free Guide

White Papers and Resources | July 2, 2024 | Petauri Evidence

We are delighted to announce that the second edition of our popular introductory guide: ‘Market access stakeholders and processes for medical devices in key European markets’ is now available. Our...

Say Goodbye to Costly Delays – Origins’ Clinical Trial Participant Simulations Have the Answer!

Press Releases | July 2, 2024 | Origins – The Patient Focused Specialists

Lack of Patient Involvement in Clinical Trial Designs Causes Major Issues Low recruitment and retention of clinical trials is a key issue faced by many clinical trials. These can lead...

Joint Clinical Assessments: bureaucratic nightmare, AI opportunity, or both?

White Papers and Resources | June 28, 2024 | Amiculum

By Manca Povsic and Andrew Dobb

Unrivalled Convenience – Perks of Virtual Medical Education

Videos and Podcasts | June 27, 2024 | Impetus Digital

Explore the unrivalled convenience of virtual collaboration in medical education with our new series, "Perks of Virtual Medical Education." Learn why this flexible, efficient mode of learning is the future...

OPEN Health and fusion announce partnership to deliver AI-powered healthcare communications

Press Releases | June 24, 2024 | OPEN Health

OPEN Health, a pre-eminent global provider of scientific communications, HEOR and market access, patient engagement, and consulting, today announced a partnership with fusion, an innovative artificial intelligence (AI) and machine...

Eyes on the horizon: six (and a half) predictions for the future of healthcare communications

White Papers and Resources | June 21, 2024 | Amiculum

By Zoë van Helmond and Leyna Prince

Unleashing Creativity in Virtual Pharma Engagements

Videos and Podcasts | June 20, 2024 | Impetus Digital

Think outside the box with virtual engagements! Discover how creative asynchronous touchpoints can revolutionize your interactions. Explore everything from OLAs to treatment pathway profiling via a pharma-compliant virtual platform.